新型冠状病毒肺炎(coronavirus disease-2019,COVID-19)已成为全球重大公共卫生事件,对现有医疗资源造成重大负担。COVID-19以轻型、普通型多见,重型-危重型所占比例虽然较少,但病死率明显升高,所需医疗资源也往往更多。多种基于其他疾病及COVID-19的评分被用于COVID-19不良预后风险的评估,其中包含社区性肺炎、病毒性肺炎、脓毒症早期识别等常用评分。但上述评分普遍存在通用性、适用性不明,高偏倚等风险。本文将对现有COVID-19评分进行归纳、总结,旨在为临床不良预后风险评估提供参考。
Coronavirus Disease-2019 (COVID-19) has been a major public health issue all over the world, placing a significant burden on available healthcare resources. The most common types of COVID-19 are the mild and common forms. Although the proportion of the severe-critical types is smaller, the rate of death is significantly higher and the medical resources required tend to be greater. Thus, a variety of scores based on other disease and COVID-19 were used to assess the risk of poor prognosis on the COVID-19, including the common scores for community-acquired pneumonia, sepsis and viral pneumonia. Unfortunately, the above scores often lacked an adequate description of the applicable population or were at high risk of bias with unknown applicability. Therefore, the article summarized the existing scores, aiming to provide a reference for clinical prognostic risk assessment
蔡芋晴,曾惠清,李琪,等. 新型冠状病毒肺炎预后临床预测评分研究进展[J]. 中华结核和呼吸杂志,2022,45(07):706-711.
DOI:10.3760/cma.j.cn112147-20211125-00837版权归中华医学会所有。
未经授权,不得转载、摘编本刊文章,不得使用本刊的版式设计。
除非特别声明,本刊刊出的所有文章不代表中华医学会和本刊编委会的观点。
蔡芋晴, 曾惠清, 李琪, 等. 新型冠状病毒肺炎预后临床预测评分研究进展[J]. 中华结核和呼吸杂志, 2022, 45(7): 706-711. DOI: 10.3760/cma.j.cn112147-20211125-00837.

你好,我可以帮助您更好的了解本文,请向我提问您关注的问题。